Diagnoz.me

Medical Diagnostics Microscope

Health Tech & Life Sciences
Non Active, Sep 2019 ceased to operate

Company Overview

Snapshot

Founded in October 2017 by Tamir Epstein and Ariel Livne, Diagnoz.me operates with 1–10 employees. The company has raised $840,000 across two funding rounds. Diagnoz.me ceased operations in September 2019.

Business overview

Diagnoz.me is developing a remote diagnostic tool designed for detecting and analyzing the microbial content of body fluids. The company's core technology enables a standard smartphone to function as a medical diagnostics microscope when paired with a proprietary, low-cost disposable device. This solution aims to allow patients to conduct lab-grade tests at home, transmitting results directly to physicians for accurate and personalized treatment, serving the global digital healthcare and medical diagnostics markets.

Strategic signal

In March 2020, Fast Company highlighted the potential for smartphones to serve as powerful medical devices, aligning with Diagnoz.me's vision of transforming smartphones into diagnostic microscopes. This article underscores the ongoing industry interest in leveraging ubiquitous consumer technology for accessible healthcare solutions, even after Diagnoz.me ceased operations in September 2019, indicating continued market validation for the underlying technological approach.

Company Intelligence Q&A

What is Diagnoz.me's primary offering?
Diagnoz.me is developing a remote diagnostic tool that allows a standard smartphone to function as a medical diagnostics microscope for detecting and analyzing microbial content in body fluids.
When was Diagnoz.me founded?
Diagnoz.me was founded in October 2017.
What is the status of Diagnoz.me?
Diagnoz.me is currently non-active and ceased to operate in September 2019.
What was the total capital raised by Diagnoz.me?
Diagnoz.me raised a total of $840,000 across two funding rounds.
What was a key technological focus for Diagnoz.me?
Diagnoz.me focused on enabling smartphones to act as medical diagnostics microscopes using a proprietary, low-cost disposable device, as highlighted in a March 2019 article by Israel21c.